We are starting the new year with some exciting strides in genetic research! A team of scientists from the Icahn School of Medicine at Mount Sinai has unveiled a groundbreaking statistical technique, #BridgePRS, to boost disease prediction accuracy in non-European populations, especially those of African descent. Key Highlights of this research include: 1. Enhanced Disease Prediction: The innovative "BridgePRS" addresses the limitations of current polygenic risk scores (PRS), predominantly tailored to individuals of European ancestry. 2. Reduced Health Care Inequities: By leveraging shared genetic effects across ancestries, this development promises more accurate disease prediction for diverse ethnic groups, fostering a future of personalized and precise medical interventions. This breakthrough is a significant step towards reducing healthcare disparities and advancing personalized medicine for all. Kudos to the talented team at Icahn School of Medicine at Mount Sinai for this impactful contribution to #genomics Read more about their pioneering work here: https://lnkd.in/dUVVFxd5 #genomics #healthcareequity #precisionmedicine #myafrodna #dnaresearch #researchinnovation
